8/13/24 16:29 | 11/30/23 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | S.m | 0 | 0.2255 | 0 | 0 | -1 | 23 | D | | | | | | | | | | | | | | |
11/8/23 16:16 | 8/4/23 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | S.m | 0 | 0.8885 | 0 | 0 | -2 | 23 | D | | | | | | | | | | | | | | |
7/19/23 16:07 | 7/6/23 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | S | 0 | 1.47 | 0 | 0 | 0 | 23 | D | | | | | | | | | | | | | | |
7/6/23 16:16 | 3/31/23 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | S.m | -1 | 2.46 | 0 | 0 | -1 | 23 | D | | | | | | | | | | | | | | |
7/6/23 16:16 | 6/30/23 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | P | 27 | 1.52 | 0 | 18 | 306 | 23 | D | | | | | | | | | | | | | | |
3/7/23 16:11 | 1/24/23 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | S.m | -4 | 8.87 | 0 | 0 | -6 | 6 | D | | | | | | | | | | | | | | |
12/20/22 16:35 | 11/28/22 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | S.m | -63 | 0.1691 | 0 | -372 | -53 | 325 | D | | | | | | | | | | | | | | |
11/10/22 16:10 | 11/4/22 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | S | -2 | 0.2725 | 0 | -8 | -2 | 333 | D | | | | | | | | | | | | | | |
10/6/22 17:29 | 10/4/22 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | S | -2 | 0.2809 | 0 | -8 | -2 | 339 | D | | | | | | | | | | | | | | |
9/12/22 16:05 | 9/6/22 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | S | -2 | 0.3900 | 0 | -5 | -1 | 347 | D | | | | | | | | | | | | | | |
8/11/22 16:30 | 8/5/22 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | S | -2 | 0.4700 | 0 | -5 | -1 | 352 | D | | | | | | | | | | | | | | |
7/6/22 16:08 | 7/1/22 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | S | -3 | 0.5500 | 0 | -5 | -1 | 357 | D | | | | | | | | | | | | | | |
6/6/22 16:49 | 6/1/22 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | S | -4 | 0.9600 | 0 | -4 | -1 | 361 | D | | | | | | | | | | | | | | |
6/1/22 14:18 | 5/31/22 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | P | 18 | 0.9211 | 0 | 20 | 6 | 366 | D | | | | | | | | | | | | | | |
5/12/22 16:05 | 5/5/22 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | S | -3 | 0.7700 | 0 | -5 | -1 | 346 | D | | | | | | | | | | | | | | |
4/8/22 16:27 | 4/1/22 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | S | -6 | 1.13 | 0 | -5 | -1 | 350 | D | | | | | | | | | | | | | | |
3/2/22 16:15 | 2/28/22 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | S | -4 | 1.06 | 0 | -4 | -1 | 355 | D | | | | | | | | | | | | | | |
2/2/22 16:22 | 1/31/22 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | S | -4 | 1.22 | 0 | -4 | -1 | 359 | D | | | | | | | | | | | | | | |
1/28/22 16:46 | 1/4/22 | RSLS | Reshape Lifesciences Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Stankovich Thomas | CA | O | CFO | S | -6 | 1.78 | 0 | -3 | -1 | 363 | D | | | | | | | | | | | | | | |